Skip to main content
Equibles
TECH logo

TECH · BIO-TECHNE Corp · Metrics

Track TECH — free

Use TECH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TECH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$72.55 -0.07 (-0.10%) At close · Oct 23
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$11.38B
Shares
156.82M
Volume · Oct 23 1.9M Avg daily vol (3M) 3.03M

TECH metrics

101 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$72.55
Market cap
$11.38B

Price action

20 metrics
Price change (1W)
0.0%
Price change (30D)
-0.1%
Price change (3M)
+1.3%
Price change (6M)
+33.9%
Price change (YTD)
+23.4%
Price change (1Y)
+9.8%
Trailing year
Price change (5Y)
—
52-week high
$72.64
52-week low
$43.30
Change from 52-week high
-0.1%
Change from 52-week low
+67.6%
Annualized volatility
43.5%
Annualized volatility (3M)
2.7%
Beta
0.8
RSI (14D)
55.0
Price vs SMA 50
+0.2%
Price vs SMA 200
+15.2%
Avg volume (3M)
3.03M
Relative volume
0.6
Average dollar volume
$219.39M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
156.82M

Valuation

12 metrics
P / E (TTM)
62.5
Trailing earnings · reciprocal yield 1.6%
PEG ratio
0.4
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
9.4×
reciprocal yield 10.7%
P / book
5.4
reciprocal yield 18.5%
FCF yield
2.3%
TTM · current market cap
Buyback yield
0.4%
P / FCF
43.2
reciprocal yield 2.3%
P / operating cash flow
39.0
reciprocal yield 2.6%
Earnings yield
1.6%

Historical valuation

8 metrics
P / E historical average (3Y)
78.7×
reciprocal yield 1.3%
P / E historical average (5Y)
75.7×
reciprocal yield 1.3%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.4%
Trailing 12 months
Payout ratio
27.4%
Shareholder yield
0.8%
Dividend / share (TTM)
$0.32
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-08-24

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-12

Profitability

9 metrics
Gross margin
65.8%
Operating margin
20.7%
Trailing 12 months
Net margin
15.0%
Gross profit (TTM)
$799.07M
Operating profit (TTM)
$251.89M
Net income (TTM)
$181.86M
Trailing 12 months
Diluted EPS (TTM)
$1.16
FCF margin
21.7%
Effective tax rate
24.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$7.74
Gross profit per diluted share (TTM)
$5.09
Operating profit per diluted share (TTM)
$1.60
EBITDA per diluted share (TTM)
$2.22
Net income per diluted share (TTM)
$1.16
Operating cash flow per diluted share (TTM)
$1.86
Free cash flow per diluted share (TTM)
$1.67
Capital expenditures per diluted share (TTM)
$0.18
R&D per diluted share (TTM)
$0.60
Stock compensation per diluted share (TTM)
$0.26
Book value per share
$13.51

Growth

11 metrics
Revenue growth YoY
+1.3%
Year over year
Net income growth YoY
+147.8%
Revenue (TTM)
$1.22B
Trailing 12 months
EPS growth YoY
+152.2%
Shares change YoY
-1.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.2%
Revenue CAGR (5Y)
+5.5%
EPS CAGR (3Y)
-13.0%
EPS CAGR (5Y)
+5.9%
FCF CAGR (3Y)
+6.8%
FCF CAGR (5Y)
-3.1%

Quality

14 metrics
Return on equity
8.6%
Return on assets
7.0%
Debt / equity
—
Current ratio
4.5
EBITDA (TTM)
$349.25M
Free cash flow (TTM)
$263.22M
Quick ratio
3.4
Interest coverage
26.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$264.71M
Total assets
$2.59B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$292.07M
Capital expenditures (TTM)
$28.85M
R&D (TTM)
$94.77M
SG&A (TTM)
$452.42M
Stock compensation (TTM)
$41.37M
R&D / revenue
7.8%
Stock compensation / revenue
3.4%

Ownership (13F)

9 metrics
13F filers
601
13F filer change QoQ
+13
Institutional ownership
112.8%
Conviction holders (share of 13F filers)
2.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-8.4%
Holder tenure
16.1
Price vs estimated holder cost
+24.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
23.9%

Short interest

3 metrics
Short interest
4.7%
Latest settlement · 2.1 days to cover
Days to cover
2.1d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 842023 CUSIP 09073M104 13F (30d) 99 filings 94 filers Visit website Investor relations